Edwards Lifesciences Corporation (EW) Net income 2016–2025
Edwards Lifesciences Corporation (EW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.1BFY2025 · since FY2016: $569.5M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | -74.3% |
| FY2024 | $4.2B | +197.7% |
| FY2023 | $1.4B | -7.9% |
| FY2022 | $1.5B | +1.3% |
| FY2021 | $1.5B | +82.5% |
| FY2020 | $823.4M | -21.3% |
| FY2019 | $1.0B | +45.0% |
| FY2018 | $722.2M | +23.7% |
| FY2017 | $583.6M | +2.5% |
| FY2016 | $569.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice